SCHEMBL9926474

SCHEMBL9926474

Cc1ccc(C)c(F)c1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.48
CD44 P16070 1/20 0.42
NOS3 P29474 2/20 0.39
NOS2 P35228 2/20 0.39
ALDH1A1 P00352 5/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
CASP1 P29466 2/20 0.36
CYP3A4 P08684 4/20 0.35
TSHR P16473 3/20 0.35
TP53 P04637 1/20 0.35
NOS1 P29475 1/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3725651 0.86 POLB (0.40) POLBCD44NOS3NOS2ALDH1A1
SCHEMBL5812365 0.83 POLB (0.44) POLBCD44NOS3NOS2ALDH1A1
SCHEMBL405898 0.83 CD44 (0.44) POLBCD44NOS3NOS2ALDH1A1
SCHEMBL13999786 0.83 POLB (0.44) POLBCD44NOS3NOS2ALDH1A1
SCHEMBL12224545 0.79 POLB (0.36) POLBCD44NOS3NOS2ALDH1A1
SCHEMBL19494456 0.79 CYP3A4 (0.43) POLBCD44NOS3NOS2ALDH1A1
SCHEMBL406843 0.79 POLB (0.36) POLBCD44NOS3NOS2ALDH1A1
SCHEMBL16117797 0.79 POLB (0.41) POLBCD44NOS3NOS2ALDH1A1
SCHEMBL14784427 0.79 PDE10A (0.48) POLBCD44NOS3NOS2ALDH1A1
SCHEMBL2778015 0.79 CYP3A4 (0.43) POLBCD44ALDH1A1TDP1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1939204-B3 FUSED HETEROCYCLIC DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF KISSEI PHARMACEUTICAL (JP) 2022-08-24 EP disclosed
EP-2220046-B1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION GILEAD SCIENCES INC (US) 2014-06-18 EP disclosed
EP-2243812-B1 Liquid crystal display MERCK PATENT GMBH (DE) 2012-06-13 EP disclosed
EP-1751139-B1 SUBSTITUTED PYRAZOLYL UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER BAYER HEALTHCARE LLC (US) 2011-07-27 EP disclosed
WO-2010074089-A1 INDANYL COMPOUNDS 第一三共株式会社 (JP) 2010-07-01 WO disclosed